Evaluation and diagnosis of the hair loss patient

Mubki, Thamer; Rudnicka, Lidia; Olszewska, Małgorzata; Shapiro, Jerry

doi:10.1016/j.jaad.2014.05.008

Cited by 115 publications

(117 citation statements)

References 57 publications

Supporting

Mentioning

103

Contrasting

Unclassified

Order By: Relevance

“…Alopecia areata may present in varying patterns. The patchy type is usually localized, whereas a more diffuse pattern has also been described [29,35].…”

Section: Differential Diagnosismentioning

confidence: 99%

“…In this age group, starting or interrupting hormonal replacement therapies should be ruled out as a possible cause of TE [29].…”

Section: Hair and Scalp Disorders 132mentioning

confidence: 99%

“…The test should be performed in four regions of the scalp: the frontal, occipital, and both temporal regions. The hair should not be shampooed for at least a day [29]. Light microscope is used to examine the hair shafts and to confirm that the loose hairs are telogen hairs [10].…”

Section: Hair Pull Testmentioning

confidence: 99%

See 2 more Smart Citations

Telogen Effluvium

Özlü¹,

Karadağ²

2017

Hair and Scalp Disorders

View full text Add to dashboard Cite

Telogen effluvium (TE) is a noninflammatory disease characterized by diffuse loss of telogen hair. It is the most frequent cause of diffuse hair loss and the actual incidence of the disease is not known. According to the underlying etiology, TE could be physiologically and pathologically classified. The evaluation of a patient with TE includes a detailed history, physical examination, and laboratory tests. The patients should be questioned in terms of TE subtype, duration, and clinical course of hair loss. The most important point in the treatment of TE is to consult about the natural course of the disease.

show abstract

“…Alopecia areata may present in varying patterns. The patchy type is usually localized, whereas a more diffuse pattern has also been described [29,35].…”

Section: Differential Diagnosismentioning

confidence: 99%

“…In this age group, starting or interrupting hormonal replacement therapies should be ruled out as a possible cause of TE [29].…”

Section: Hair and Scalp Disorders 132mentioning

confidence: 99%

See 1 more Smart Citation

Telogen Effluvium

Özlü¹,

Karadağ²

2017

Hair and Scalp Disorders

View full text Add to dashboard Cite

show abstract

“…The handle dermoscopy usually has a 10-fold magnification of the skin surface while the video dermoscope, which is equipped with a software, will have the benefit of larger magnification (ranging from 10-70 fold) and the conversion of measurement results into a database Trichoscopy adds important information for establishing the correct diagnosis and it is also a useful tool for assessing disease activity and monitoring treatment efficacy [18,60,61].…”

Section: Pathophysiology Of Androgenetic Alopeciamentioning

confidence: 99%

“…The most important trichoscopic feature is hair shaft thickness heterogeneity, which means the presence of hairs with different thickness such as thin, intermediate and thick hairs [61]. Other features include vellus hairs (decreased terminal to vellus hair ratio), predominance of HF units with single hairs, yellow dots (hair follicles filled with hyperkeratotic plugs), perifollicular discolouration, wavy hair and honeycomb pigmentation [60,62].…”

Section: Pathophysiology Of Androgenetic Alopeciamentioning

confidence: 99%

Androgenetic Alopecia: a Review and Emerging Treatments

Alves¹

2017

CRDOA

View full text Add to dashboard Cite

Androgenetic Alopecia (AGA) is the most common noncicatricial alopecia that leads to the progressive miniaturization of the hair follicle. Scalp terminal hairs are converted into vellus hairs, primarily due to two factors: genetic predisposition and hormonal stimulation.The incidence and prevalence of AGA increases with age. The onset of AGA is gradual, and when this pathology progresses, the anagen phase shortens and the telogen phase remains constant. The shedding area varies from patient to patient and is usually most marked at the vertex in men, while women with AGA generally lose hair diffusely over the crown.Topical minoxidil and oral finasteride (5-alpha-reductase type II inhibitor) are the gold-standard therapies for AGA and are currently the only Food and Drug Administration (FDA)-approved drugs for the treatment of AGA.The currently available treatments for AGA are sometimes perceived as having limited effectiveness; therefore, the identification of new therapies for this pathology is of utmost importance.This article aims to review the pathogenesis, diagnosis of AGA and all the new emerging treatments for this entity in order to prevent its progression and improve the results of this pathology.

show abstract

Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021

Mirmirani

2021

JAMA

View full text Add to dashboard Cite

show abstract

Evaluation and diagnosis of the hair loss patient

Cited by 115 publications

References 57 publications

Telogen Effluvium

Telogen Effluvium

Androgenetic Alopecia: a Review and Emerging Treatments

Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021

Contact Info

Product

Resources

About